Trial Profile
Ticagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Aug 2013
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes; Thrombosis
- Focus Pharmacodynamics
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
- 29 Aug 2012 Status changed from recruiting to completed.
- 23 Jul 2012 New trial record